Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire

INTRODUCTION: Understanding patients’ preferences for long-acting injectable (LAI) or oral antipsychotics (pills) could help reduce potential barriers to LAI use in schizophrenia. METHODS: Post hoc analyses were conducted from a double-blind, randomized, non-inferiority study (NCT01515423) of 3-mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackwood, Clifton, Sanga, Panna, Nuamah, Isaac, Keenan, Alexander, Singh, Arun, Mathews, Maju, Gopal, Srihari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342487/
https://www.ncbi.nlm.nih.gov/pubmed/32753849
http://dx.doi.org/10.2147/PPA.S251812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342487/
https://www.ncbi.nlm.nih.gov/pubmed/32753849
http://dx.doi.org/10.2147/PPA.S251812

Ejemplares similares